Sanford Baim

Internal Medicine physician in Chicago, Illinois — also lists obesity medicine in the CMS registry.

Practice Details

Address
1725 W Harrison St Ste 250
Chicago, IL 60612
Geocoded location: 41.8741, -87.6702
Taxonomy
Internal Medicine
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2006
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
July 2023

Specialty taxonomies on file (3)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
  • Internal Medicine
    Internal Medicine, Rheumatology
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Sanford Baim is an Internal Medicine physician in Chicago whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 4435 Internal Medicine practices in Chicago carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Sanford Baim's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 312-942-6163.

GLP-1 access in Chicago, Illinois

Adult obesity rate
32.4%
#26 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Illinois telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Illinois Medicaid, obesity indication

About 32.4% of Illinois adults have obesity (BMI 30+), ranking the state #26 of 50 (CDC BRFSS). Our directory currently lists 314 GLP-1-relevant clinics in Chicago. If a cash-pay route makes more sense, compounded semaglutide through Illinois telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Illinois options on the best Illinois GLP-1 providers page, browse every Chicago listing in the Chicago clinic directory, or read the Illinois Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Chicago

Other Chicago listings in the same directory tier:

Ruchi Fitzgerald
Family Medicine
Sebastian Dobrow
Internal Medicine
Peter Friedell
Internal Medicine

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Illinois addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Illinois telehealth partners:

Featured Partners · Chicago

Featured GLP-1 providers serving Chicago

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 177 GLP-1 providers serving Chicago ↓

See more Chicago options on the Chicago clinic directory, our Chicago GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Chicago obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Sanford Baim's specialty taxonomy but not the specific medications it prescribes or its current service menu. Sanford Baim is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 312-942-6163 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Sanford Baim's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Sanford Baim is located at 1725 W Harrison St Ste 250, Chicago, IL 60612. The phone number listed in the registry is 312-942-6163. Its full record is public in the CMS National Provider registry under NPI 1841227311.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Sanford Baim is currently accepting new patients. Call the practice at 312-942-6163 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.